Biotron Drug Effective Against COVID-19 In Animals
BIT225 administered orally significantly reduced viral load in the lungs and blood of animals challenged with SARS-CoV-2. BIT225 protected against severe...
Stay updated with breaking news from Professor Rob Murphy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BIT225 administered orally significantly reduced viral load in the lungs and blood of animals challenged with SARS-CoV-2. BIT225 protected against severe...
Biotron (ASX:BIT) has announced that its lead clinical asset, BIT225, has demonstrated substantial and clinically meaningful efficacy against
BIT225 administered orally significantly reduced viral load in the lungs and blood of animals challenged with SARS-CoV-2.
BIT225 administered orally significantly reduced viral load in the lungs and blood of animals challenged with SARS-CoV-2. BIT225 protected against severe...
BIT225 administered orally significantly reduced viral load in the lungs and blood of animals challenged with SARS-CoV-2. BIT225 protected against...